Definitions
from Wiktionary, Creative Commons Attribution/Share-Alike License.
- noun A
protease inhibitor being studied as a treatment forhepatitis C .
Etymologies
Sorry, no etymologies found.
Support
Help support Wordnik (and make this page ad-free) by adopting the word boceprevir.
Examples
-
Clinical-trial results released so far indicate that both telaprevir and boceprevir appear to work much better than the current treatment, though doctors might prefer telaprevir because it seems easier to use, said Jorge Herrera, a University of South Alabama hepatologist who was an investigator in boceprevir trials and has been traveling around the country lecturing doctors about using the new treatments.
Strides Against Hepatitis C Open Door to Blockbusters Jonathan D. Rockoff 2010
-
a third antiviral medication called boceprevir, new research suggests.
-
But as many as 68% of those also receiving boceprevir achieved sustained response at 28 weeks, the researchers found.
-
Now major studies show that adding a new drug —either Vertex Pharmaceuticals' telaprevir or Merck & Co.'s boceprevir — can boost those cure rates as high as 75%.
-
For black patients, the response rate was 23% for those receiving standard care and up to 53% with the addition of boceprevir.
-
According to studies presented at a recent medical meeting, 67% to 75% of patients given treatment including either boceprevir or telaprevir, respectively, had what doctors call a cure.
-
The future looks very bright beyond telaprevir and boceprevir, notes Dr. Fred Poordad of Cedars-Sinai Medical Center in Los Angeles, who has studied both drugs and consults for several companies.
-
The future looks very bright beyond telaprevir and boceprevir, notes Dr. Fred Poordad of Cedars-Sinai Medical Center in Los Angeles, who has studied both drugs and consults for several companies.
-
According to studies presented at a recent medical meeting, 67% to 75% of patients given treatment including either boceprevir or telaprevir, respectively, had what doctors call a cure.
-
Now major studies show that adding a new drug —either Vertex Pharmaceuticals' telaprevir or Merck & Co.'s boceprevir — can boost those cure rates as high as 75%.
Comments
Log in or sign up to get involved in the conversation. It's quick and easy.